Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for ...

Research shows weight loss surgery can help reduce the risk of severe liver problems for some patients with MASH.

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

A study found that if metabolic abnormal fatty liver disease persists, people have a 57% higher risk of cardiovascular ...

A deeper understanding of a gene that predisposes patients to fatty liver disease may open new avenues for treatment of the ...

Fact checked by Nick Blackmer Fatty liver disease is often called a “silent epidemic” because it can progress for years ...

About 84 per cent IT employees in India have fatty liver disease while around 71 per cent are obese, says a study ...

Fatty liver disease occurs when more than 5-10% of the liver's weight is made up of fat. This can lead to inflammation in the ...

Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...

The aim of the SPECCIAL (Surgical Procedures Eliminate Compensated Cirrhosis In Advancing Long-term) study was to examine the long-term outcomes of bariatric surgery on the risk of developing major ...

Learn how the Mediterranean diet can help manage and even reverse MASH by supporting liver health, reducing inflammation, and ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...